# Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

> **NCT00224445** · PHASE4 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 100 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Truvada
- **DRUG:** Atazanavir
- **DRUG:** Ritonavir

## Key facts

- **NCT ID:** NCT00224445
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2007-01
- **Final completion:** 2007-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2013-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00224445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00224445, "Boosted Atazanavir and Truvada Given Once-Daily - BATON Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00224445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*